Hearing Aid Manufacturing in European Union: Market Size, Businesses & Forecast 2026

The Hearing Aid Manufacturing industry in the European Union involves the design, fabrication, and distribution of advanced electroacoustic medical devices and smart hearing implants designed to alleviate hearing impairment. The sector is moving rapidly toward increased digital integration, featuring artificial intelligence, wireless connectivity, and rechargeable technologies to support healthy aging. Reflecting this sustained demand, member companies of the European Hearing Instrument Manufacturers Association (EHIMA) reported record global unit sales of 23.16 million hearing aids in 2025 (EHIMA 2026), marking a steady expansion from 22.69 million units in 2024.

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Hearing Aid Manufacturing in European Union industry cover?

This industry encompasses establishments primarily engaged in the research, development, and manufacturing of electronic hearing instruments, including behind-the-ear (BTE), in-the-ear (ITE), and receiver-in-canal (RIC) devices. The scope extends to related clinical fitting software, smartphone applications, assistive listening accessories, and advanced auditory implants. Under official statistical classification frameworks, these activities are categorized under the broader manufacture of irradiation, electromedical, and electrotherapeutic apparatus.

• •Covers the fabrication of electronic hearing systems, sound processors, and specialized audiological fitting platforms.
• •Includes secondary accessories such as wireless remote microphones, charging stations, and Bluetooth connectivity modules.
• •Excludes purely retail audiology services, general optics, and nonelectrical medical equipment manufacturing lines.

Who operates in the industry and how is it structured?

The European Union serves as the global hub for hearing instrument manufacturing, hosting a highly consolidated cluster of multi-national operators that command a dominant share of the worldwide market. Production relies on high-tech automated assembly lines, precision micro-molding, and advanced semiconductor packaging. Manufacturers primarily distribute their products via dual channels, including independent audiologist networks, public healthcare tenders, and vertically integrated retail chains owned by the manufacturers themselves.

• •Characterized by high consolidation where a handful of European-headquartered engineering groups control the vast majority of commercial production.
• •Utilizes a blended B2B wholesale approach alongside manufacturer-owned corporate retail operations across EU member states.
• •Relies heavily on centralized European research and development facilities paired with regional assembly and fulfillment centers.

What drives demand in the industry?

The primary catalyst for the industry is the demographic shift within the European Union, characterized by an aging population and a corresponding rise in age-related sensorineural hearing loss. According to public health data published by EHIMA, approximately 1 in 10 individuals across the total EU population reports experiencing hearing loss. Demand is further accelerated by expanding public reimbursement policies in select member states and growing medical recognition linking untreated hearing impairment to cognitive decline and social isolation.

• •An estimated 22.6 million individuals within the European Union live with untreated, disabling hearing loss, representing a massive unpenetrated market (EHIMA 2025).
• •Untreated hearing impairment incurs an estimated €185 billion in annual societal and economic costs across the EU and UK (Brunel University London Study).
• •Only about 1 in 3 individuals with recognized hearing loss currently utilizes professionally fitted hearing instruments.

Who are the notable companies in the industry?

The competitive environment features intense technological rivalry among a small group of large, publicly traded multinationals holding deep intellectual property portfolios. Companies compete fiercely on the basis of chip processing speed, spatial audio algorithms, battery efficiency, and cosmetic appeal. Major European entities drive the global innovation curve, leveraging extensive manufacturing facilities and global distribution networks.

• •Demant A/S (formerly William Demant Holding), a prominent Danish hearing healthcare group operating major manufacturing and audiology brands.
• •GN Store Nord A/S, headquartered in Denmark, which develops intelligent audio and hearing solutions through its GN Hearing division.
• •Sonova Holding AG, a leading global provider headquartered in Switzerland with vast operational, manufacturing, and retail footprints across the EU.
• •WSAudiology A/S, formed through the merger of Denmark's Widex and Germany's Sivantos, maintaining extensive manufacturing facilities in Europe.

What are the recent trends and outlook?

Recent product development is dominated by the integration of advanced artificial intelligence for real-time acoustic environment classification and automated noise reduction. The market is also experiencing a permanent shift toward lithium-ion rechargeable platforms and the adoption of the latest Bluetooth LE Audio standards. Global volumes continue an upward trajectory, with EHIMA tracking consecutive annual increases from 20.25 million units in 2022 to 21.81 million units in 2023, and 22.69 million units in 2024.

• •Global unit sales by major manufacturers reached 23.16 million units in 2025, a 2.1% year-over-year increase (EHIMA 2026).
• •Rapid adoption of Over-The-Counter (OTC) and self-fitting software architectures alongside traditional premium, professionally fitted devices.
• •Heightened focus on circular economy initiatives, including eco-design principles and plastic reduction in device packaging.

How is the industry regulated?

Manufacturing operations within the EU are governed by rigorous regulatory frameworks that mandate extensive clinical validation and quality management oversight. The transition from the legacy Medical Devices Directive (MDD) to the strict European Medical Device Regulation (MDR) has significantly altered compliance landscapes. This transition demands robust post-market surveillance, precise Unique Device Identification (UDI) tracking, and exhaustive human clinical data for all device tiers.

• •Compliance with Regulation (EU) 2017/745 (MDR) is mandatory for all hearing instruments, fitting software, and apps sold in the European market.
• •The MDR framework requires extensive technical documentation, biological safety testing, and multi-month clinical investigation pipelines.
• •Products must achieve CE mark certification under risk-based classifications before gaining access to the single internal EU market.

Government, statistical and trade sources used for this Claight analysis.

• European Hearing Instrument Manufacturers Association (EHIMA) Global Sales Report 2026 ·
• European Hearing Instrument Manufacturers Association (EHIMA) Key Facts 2025 ·
• Official Journal of the European Union, Regulation (EU) 2017/745 (MDR) ·
• Eurostat NACE Rev. 2 Statistical Classification ·
• Brunel University London Study (Hearing Loss - Numbers and Costs) 2019